Tempus AI, Inc (TEM)
After hours:
- Business Wire
Tempus Announces Real World Data Collaboration with BioNTech
CHICAGO, September 04, 2024--Tempus AI, Inc. (NASDAQ: TEM, "Tempus"), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a multi-year collaboration with BioNTech SE (Nasdaq: BNTX, "BioNTech"), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. This collaboration leverages Tempus' robust multimodal datasets in support of BioNTech’s next-generation oncology pipeline.
- Business Wire
Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
CHICAGO, August 28, 2024--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held in New York, NY.
- Insider Monkey
Is Tempus AI Inc (NASDAQ:TEM) The Best Small-Cap AI Stock to Buy?
We recently published a list of Top 10 Trending AI Stocks on Latest Analyst Ratings and News. Since Tempus AI Inc (NASDAQ:TEM) ranks 10th on the list, it deserves a deeper look. AI stocks have pulled back considerably over the past few weeks and analysts believe this is exactly the healthy correction long-term investors were looking for. […]
